Monsanto provides concise summaries of documents in 3 sentences or less.
Monsanto has shifted from crop chemicals to seeds and traits, with seeds and traits expected to generate $9.1 billion in sales by 2008 compared to $7.6 billion for the entire agricultural industry in 1996. Monsanto leads the seed and trait market through its strong germplasm and biotechnology offerings for major crops like corn, soybeans, and cotton. Monsanto's research and development pipeline focuses on elite germplasm, biotechnology traits, and other innovations to deliver benefits to farmers, processors, and consumers.
Brett Begeman, Executive Vice President of International Commercial at Citigroup Investment Research, presented at the 16th Annual Investment Conference on December 7, 2005. The presentation included forward-looking statements and defined non-GAAP financial measures. It provided an overview of Monsanto's two-step strategy to grow its current portfolio globally and lead through innovation. Monsanto sources the world's corn and soy needs, and acceleration in seeds and traits is driving commercial gross profit evolution.
This document provides an overview and schedule for Monsanto's "Whistle Stop III" investor event focusing on their soybean and corn platforms. Key points include:
- Monsanto's five-year plan aims to double gross profit by 2012 by more than doubling their seeds and traits segment through innovations in corn and soybeans.
- For 2008, corn seeds and traits are forecast to grow 25% while soybeans are forecast 15% growth with preparations for the Roundup Ready 2 Yield launch.
- For 2009, corn seeds are forecast 25-30% growth while soybeans are forecast over 5% growth with the Roundup Ready 2 Yield commercial release in soybeans.
- The two-day
The document provides an overview of Monsanto's financial results for the first quarter of 2009 and outlook. Key points include:
- Net sales increased 29% to $2.6 billion compared to first quarter 2008.
- Net income increased 117% to $556 million.
- Gross profit from Roundup and other glyphosate herbicides increased 65% due to price increases globally and strength in Brazil.
- Corn and soybean seed and traits also saw gross profit increases of 41% and 31% respectively.
- Guidance for full year 2009 forecasts ongoing earnings per share growth of 20-24% and continued growth across major business segments.
The document discusses opportunities for growth at Monsanto across several business segments through 2010. It outlines opportunities to increase market share and trait adoption in U.S. corn, expand internationally into markets like Europe, Africa, Latin America and Asia, and continue commercializing biotech traits globally, especially soybeans, cotton and corn. Capturing these opportunities could increase Monsanto's gross profit margin from its current level to a target range of 51-53% by 2010.
1) Monsanto is acquiring Emergent Genetics, the third-largest player in key cotton markets in the US and India, for $300 million plus working capital adjustments.
2) The acquisition will accelerate Monsanto's growth in high-value cotton seeds and traits by providing access to Emergent's germplasm, seed market share, and established brands.
3) Significant synergies are expected from the acquisition, including $5-6 million in annual SG&A cost reductions, as well as increased seed market share and trait penetration over the next four years.
1) Monsanto has established strategic platforms in high-value crops like corn, soybeans, cotton, and vegetables through its seed and trait crop platforms.
2) Acquisitions of Seminis and Emergent are expected to add to Monsanto's earnings per share and free cash flow forecasts in the coming years.
3) With the additions of Seminis and Emergent, Monsanto has raised the bar for leadership in the global seeds market in terms of total seed and trait revenue.
Monsanto announced the acquisition of Seminis, a leading global vegetable and fruit seed company, for $1.4 billion plus a performance-based payment of up to $125 million. The acquisition supports Monsanto's strategy of shifting from crop chemicals to seeds and traits. It provides Monsanto with a ready-made leading position in the high-growth vegetable seed segment. The deal is expected to be accretive to earnings and free cash flow in fiscal year 2006 and close in the third quarter of fiscal year 2005 pending regulatory approvals.
1) Monsanto's two-step strategy through 2010 aims to first grow its current seed and trait portfolio globally and then lead through innovation and in increasingly competitive markets.
2) Key opportunities for growth include expanding corn market share in Europe, India, and Argentina through global breeding programs and channel strategies tailored for each market.
3) Continued adoption of second-generation stacked traits in major crops and markets like India, Australia, and Brazil will drive additional value and market expansion through the end of the decade.
Brett Begeman, Executive Vice President of International Commercial at Citigroup Investment Research, presented at the 16th Annual Investment Conference on December 7, 2005. The presentation included forward-looking statements and defined non-GAAP financial measures. It provided an overview of Monsanto's two-step strategy to grow its current portfolio globally and lead through innovation. Monsanto sources the world's corn and soy needs, and acceleration in seeds and traits is driving commercial gross profit evolution.
This document provides an overview and schedule for Monsanto's "Whistle Stop III" investor event focusing on their soybean and corn platforms. Key points include:
- Monsanto's five-year plan aims to double gross profit by 2012 by more than doubling their seeds and traits segment through innovations in corn and soybeans.
- For 2008, corn seeds and traits are forecast to grow 25% while soybeans are forecast 15% growth with preparations for the Roundup Ready 2 Yield launch.
- For 2009, corn seeds are forecast 25-30% growth while soybeans are forecast over 5% growth with the Roundup Ready 2 Yield commercial release in soybeans.
- The two-day
The document provides an overview of Monsanto's financial results for the first quarter of 2009 and outlook. Key points include:
- Net sales increased 29% to $2.6 billion compared to first quarter 2008.
- Net income increased 117% to $556 million.
- Gross profit from Roundup and other glyphosate herbicides increased 65% due to price increases globally and strength in Brazil.
- Corn and soybean seed and traits also saw gross profit increases of 41% and 31% respectively.
- Guidance for full year 2009 forecasts ongoing earnings per share growth of 20-24% and continued growth across major business segments.
The document discusses opportunities for growth at Monsanto across several business segments through 2010. It outlines opportunities to increase market share and trait adoption in U.S. corn, expand internationally into markets like Europe, Africa, Latin America and Asia, and continue commercializing biotech traits globally, especially soybeans, cotton and corn. Capturing these opportunities could increase Monsanto's gross profit margin from its current level to a target range of 51-53% by 2010.
1) Monsanto is acquiring Emergent Genetics, the third-largest player in key cotton markets in the US and India, for $300 million plus working capital adjustments.
2) The acquisition will accelerate Monsanto's growth in high-value cotton seeds and traits by providing access to Emergent's germplasm, seed market share, and established brands.
3) Significant synergies are expected from the acquisition, including $5-6 million in annual SG&A cost reductions, as well as increased seed market share and trait penetration over the next four years.
1) Monsanto has established strategic platforms in high-value crops like corn, soybeans, cotton, and vegetables through its seed and trait crop platforms.
2) Acquisitions of Seminis and Emergent are expected to add to Monsanto's earnings per share and free cash flow forecasts in the coming years.
3) With the additions of Seminis and Emergent, Monsanto has raised the bar for leadership in the global seeds market in terms of total seed and trait revenue.
Monsanto announced the acquisition of Seminis, a leading global vegetable and fruit seed company, for $1.4 billion plus a performance-based payment of up to $125 million. The acquisition supports Monsanto's strategy of shifting from crop chemicals to seeds and traits. It provides Monsanto with a ready-made leading position in the high-growth vegetable seed segment. The deal is expected to be accretive to earnings and free cash flow in fiscal year 2006 and close in the third quarter of fiscal year 2005 pending regulatory approvals.
1) Monsanto's two-step strategy through 2010 aims to first grow its current seed and trait portfolio globally and then lead through innovation and in increasingly competitive markets.
2) Key opportunities for growth include expanding corn market share in Europe, India, and Argentina through global breeding programs and channel strategies tailored for each market.
3) Continued adoption of second-generation stacked traits in major crops and markets like India, Australia, and Brazil will drive additional value and market expansion through the end of the decade.
The document discusses Monsanto's acquisition of Delta and Pine Land for $1.5 billion. The acquisition will create a new global cotton platform and allow Monsanto to accelerate the penetration of biotech traits. It is expected to be accretive to earnings in the second year and contribute positively to operating cash in the first year. The deal will require regulatory approval and Monsanto may divest its Stoneville cotton seed business. The combined company will have the most advanced seeds and traits portfolio and commercial distribution channels in cotton globally.
Terry Crews, Chief Financial Officer of Bank of America, presented at the 38th Annual Investment Conference on September 16, 2008. The presentation discussed Monsanto's growth opportunity in agricultural productivity through increased demand for yield and innovation to meet that demand. Monsanto aims to double its gross profit from 2007 to 2012 through expanding its seed footprint and introducing valuable biotech traits. Corn seeds and traits were highlighted as demonstrating strong financial growth and momentum through increased market share and trait penetration.
- Net sales for Q1 2006 were $1.405 billion, up 31% from $1.072 billion in Q1 2005. Gross profit was $634 million, up 29% from $491 million. Net income was $59 million compared to a net loss of $40 million in Q1 2005.
- Guidance for FY2006 targets earnings per share on an ongoing basis in the range of $2.35-$2.50 toward the upper end. Free cash flow is expected to be $825-$900 million.
- Success with variable-based pricing for Bollgard cotton traits showed increased penetration in marginal to modest infestation zones, driving overall increased value capture per acre over
Terry Crews, CFO of Monsanto, outlined financial targets for 2006-2007 focusing on accelerated growth from seeds and traits. Key targets included 20% EPS growth each year, free cash flow of $825-900M in 2006 and $875-950M in 2007, and increased seeds and traits gross profit reaching $2.3B in 2006 and $2.6B in 2007. Consistency and discipline driving growth in the current portfolio, expanding globally, and progressing the pipeline would remain cornerstones of Monsanto's strategy.
Terry Crews, Chief Financial Officer of Monsanto Company, presented at the UBS Best of Americas Conference on May 31, 2006. Monsanto is an agricultural company focused on helping farmers increase their productivity and profitability through seeds and traits. Their strategy is played out across four core crop franchises: corn, cotton, soybeans, and vegetables. Breeding and biotechnology provide parallel paths to develop products that enhance yield, and the successful application of traits in corn opens opportunities to replicate this strategy in other crops to drive continued growth.
Monsanto reported strong financial results for the fourth quarter and full fiscal year 2008. Net sales increased 35% in the fourth quarter and 36% for the full fiscal year. Diluted EPS on an ongoing basis improved 83% in the fourth quarter and 84% for the full fiscal year. Seeds and traits segments all saw gross profit increases. Over 70% of $2.8 billion in operating cash was used for acquisitions, technology collaborations, and capital investments to support growth. Monsanto expects another year of double-digit earnings growth in 2009, driven by continued strength in seeds and traits.
The document promotes a newsletter that provides penny stock picks claiming to generate large profits. It also advertises a documentary about the Federal Reserve's monetary policies. The newsletter promises to reveal stocks in a free e-newsletter that have generated gains of over 392% and 795% for previous subscribers. It lists some past penny stock picks and their returns.
This document provides a financial summary and strategic review for Monsanto for the fourth quarter and full year of 2006. Some key points:
- Net sales for Q4 2006 were $1.39 billion, up 9% from Q4 2005. Full year 2006 net sales were $7.34 billion, up 17% from 2005.
- Reported EPS for Q4 2006 was $-0.27 per share, down 17% from Q4 2005. Full year 2006 reported EPS was $1.25 per share, up 166% from 2005.
- The company achieved market share gains in key crops like US corn and soybeans as well as international markets like France and Italy.
- Opportunities for continued
Food Prices and Food Security: Overview of
Existing Data and Policy Tools and Identification of Gaps
Presented by Maximo Torero at the AGRODEP Workshop on Analytical Tools for Food Prices
and Price Volatility
June 6-7, 2011 • Dakar, Senegal
For more information on the workshop or to see the latest version of this presentation visit: http://www.agrodep.org/first-annual-workshop
Farmers purchase seeds from multiple brands and dealers to diversify their risk. They typically plant 3-4 brands and 5-8 varieties of corn, with 60% selecting germplasm first before choosing biotech traits. Purchases are made from 2-3 dealers in November and December. 38% of the corn is the latest top-yielding hybrids, with the goal of maximizing yield while minimizing risk through genetic diversity.
The document provides an overview of JBS S.A., a leading global protein producer, for the first quarter of 2010. Key highlights include:
- Net revenue increased 35.4% year-over-year to R$12.55 billion due to acquisitions.
- EBITDA increased 307.5% to R$862 million with margins improving from 2.3% to 6.9%.
- Net profit was R$99.4 million compared to a prior year loss of R$322.7 million.
- The US beef business posted a record EBITDA of US$170.5 million and 6% margins for the quarter.
- Mercosul
Jerzy Plewa, Deputy Director General for International Affairs, DG Agriculture and Rural Development
14th May 2008, Royal Museum for Central Africa in Tervuren, Belgium
The document discusses Monsanto's strategy around seeds and traits for corn. It notes that Monsanto has invested over $5 billion in seeds-and-traits R&D over 10 years. It also discusses Monsanto's leadership in developing and commercializing biotech traits for corn and how the company is focused on delivering total performance to farmers through high-yielding seeds and trait packages. Finally, it provides examples of how drought-tolerant corn in development could create value by accessing new market acres in the U.S., Brazil, and Argentina.
Braskem reported its 3Q10 results, with EBITDA of R$1,030 million. Crackers operated at over 90% capacity. Domestic resin sales rose 17% over 2Q10. Braskem is committed to financial solidity, lowering its net debt/EBITDA ratio. It raised $450 million in perpetual bonds. Integration of Quattor is advancing, with synergies of R$235 million in 2011 EBITDA. Braskem aims to be a global leader in biopolymers and sustainable chemicals through projects like Green PE and expanding use of renewable feedstock.
- The document provides financial results and forecasts for Monsanto Company for the second quarter of 2007 and fiscal year 2007.
- Net sales for the second quarter of 2007 were $2.6 billion, up 15% from the previous year. Earnings per share on an as-reported basis were $0.98, up 25% from the prior year.
- For fiscal year 2007, Monsanto increased guidance and now expects earnings per share of $1.60-1.65, representing 22-26% growth over the previous year, and free cash flow of $875-950 million.
Brett Begemann, Executive Vice President of Monsanto, presented at an investor day on November 8, 2007. He outlined Monsanto's strategic plan to double gross profit from soybeans over the next 5 years through the launch of its Roundup Ready 2 Yield soybean technology. This new technology was shown to provide a 7-11% yield advantage over previous Roundup Ready soybeans. Monsanto planned to launch Roundup Ready 2 Yield on 5-6 million U.S. acres by 2010-2012 and expected it to more than compensate for any competitive offerings in the marketplace.
This document discusses Monsanto's commercial strategy for corn traits and seeds. It outlines three pathways for mid-term growth: 1) increasing penetration and expansion of existing traits like Roundup Ready Corn 2, 2) stacking more traits into seeds, and 3) developing second-generation traits. The strategy aims to supply corn products to three channels of the market through brands like DEKALB and Asgrow, the American Seeds Inc. regional channel, and licensees. Molecular breeding is accelerating the integration of traits into higher performing seeds.
Hugh Grant, Chairman and CEO of Monsanto, presented at the Goldman Sachs Agricultural Biotech Forum. In the presentation, Grant discussed Monsanto's focus on seeds and traits, which have driven strong gross profit growth. He outlined Monsanto's strategy to extend its leadership in seeds and traits through 2010 by leveraging six growth opportunities. Grant also reviewed Monsanto's corn seed and trait performance in the U.S., noting its strength in key maturity zones is translating to increased market share. He projected demand from ethanol will provide a further boost for Monsanto's corn technology. Internationally, Grant noted Monsanto's seed business provides varying levels of profit opportunity in major corn markets.
Seminis is focused on developing new vegetable seed products, particularly in high-value crops like tomatoes, peppers, cucumbers, and melons. One key product is a raised head broccoli variety that enables mechanical harvesting, which can significantly reduce labor costs compared to traditional broccoli harvesting. Seminis is developing commercial raised head broccoli varieties and testing prototypes to prepare for product launches targeting major markets like the U.S., U.K., and Spain. The new variety is expected to bring the cost of harvesting into the value of the seed.
- Monsanto reported strong financial results for the first quarter of 2009, with net sales increasing 29% and net income up 117% compared to the first quarter of 2008.
- Gross profit for Roundup and other glyphosate-based herbicides increased 65% driven by higher prices globally and strength in Brazil.
- Corn and soybean seed and traits segments are performing well with U.S. orders on track and international launches progressing as planned.
- Monsanto reiterated fiscal year 2009 ongoing earnings growth guidance of 20-24% and free cash flow projection of over $1.8 billion.
- Monsanto reported strong financial results for the first quarter of 2009, with net sales increasing 29% and net income up 117% compared to the first quarter of 2008.
- Gross profit for Roundup and other glyphosate-based herbicides increased 65% driven by higher prices globally and strength in Brazil.
- Corn and soybean seed and traits segments are performing well with U.S. orders on track and international launches progressing as planned.
- Monsanto reiterated fiscal year 2009 ongoing earnings growth guidance of 20-24% and free cash flow projection of over $1.8 billion.
This document provides an overview of an investor tour of Seminis Research Headquarters scheduled for August 1-2, 2005. It includes forward-looking statements and discusses various risks and uncertainties that could impact financial results. It also notes that certain non-GAAP financial measures such as free cash flow and return on capital will be used and includes reconciliations to GAAP measures. Finally, it outlines the company and industry overview and research and development overview presentations that will take place during the tour.
The document discusses Monsanto's acquisition of Delta and Pine Land for $1.5 billion. The acquisition will create a new global cotton platform and allow Monsanto to accelerate the penetration of biotech traits. It is expected to be accretive to earnings in the second year and contribute positively to operating cash in the first year. The deal will require regulatory approval and Monsanto may divest its Stoneville cotton seed business. The combined company will have the most advanced seeds and traits portfolio and commercial distribution channels in cotton globally.
Terry Crews, Chief Financial Officer of Bank of America, presented at the 38th Annual Investment Conference on September 16, 2008. The presentation discussed Monsanto's growth opportunity in agricultural productivity through increased demand for yield and innovation to meet that demand. Monsanto aims to double its gross profit from 2007 to 2012 through expanding its seed footprint and introducing valuable biotech traits. Corn seeds and traits were highlighted as demonstrating strong financial growth and momentum through increased market share and trait penetration.
- Net sales for Q1 2006 were $1.405 billion, up 31% from $1.072 billion in Q1 2005. Gross profit was $634 million, up 29% from $491 million. Net income was $59 million compared to a net loss of $40 million in Q1 2005.
- Guidance for FY2006 targets earnings per share on an ongoing basis in the range of $2.35-$2.50 toward the upper end. Free cash flow is expected to be $825-$900 million.
- Success with variable-based pricing for Bollgard cotton traits showed increased penetration in marginal to modest infestation zones, driving overall increased value capture per acre over
Terry Crews, CFO of Monsanto, outlined financial targets for 2006-2007 focusing on accelerated growth from seeds and traits. Key targets included 20% EPS growth each year, free cash flow of $825-900M in 2006 and $875-950M in 2007, and increased seeds and traits gross profit reaching $2.3B in 2006 and $2.6B in 2007. Consistency and discipline driving growth in the current portfolio, expanding globally, and progressing the pipeline would remain cornerstones of Monsanto's strategy.
Terry Crews, Chief Financial Officer of Monsanto Company, presented at the UBS Best of Americas Conference on May 31, 2006. Monsanto is an agricultural company focused on helping farmers increase their productivity and profitability through seeds and traits. Their strategy is played out across four core crop franchises: corn, cotton, soybeans, and vegetables. Breeding and biotechnology provide parallel paths to develop products that enhance yield, and the successful application of traits in corn opens opportunities to replicate this strategy in other crops to drive continued growth.
Monsanto reported strong financial results for the fourth quarter and full fiscal year 2008. Net sales increased 35% in the fourth quarter and 36% for the full fiscal year. Diluted EPS on an ongoing basis improved 83% in the fourth quarter and 84% for the full fiscal year. Seeds and traits segments all saw gross profit increases. Over 70% of $2.8 billion in operating cash was used for acquisitions, technology collaborations, and capital investments to support growth. Monsanto expects another year of double-digit earnings growth in 2009, driven by continued strength in seeds and traits.
The document promotes a newsletter that provides penny stock picks claiming to generate large profits. It also advertises a documentary about the Federal Reserve's monetary policies. The newsletter promises to reveal stocks in a free e-newsletter that have generated gains of over 392% and 795% for previous subscribers. It lists some past penny stock picks and their returns.
This document provides a financial summary and strategic review for Monsanto for the fourth quarter and full year of 2006. Some key points:
- Net sales for Q4 2006 were $1.39 billion, up 9% from Q4 2005. Full year 2006 net sales were $7.34 billion, up 17% from 2005.
- Reported EPS for Q4 2006 was $-0.27 per share, down 17% from Q4 2005. Full year 2006 reported EPS was $1.25 per share, up 166% from 2005.
- The company achieved market share gains in key crops like US corn and soybeans as well as international markets like France and Italy.
- Opportunities for continued
Food Prices and Food Security: Overview of
Existing Data and Policy Tools and Identification of Gaps
Presented by Maximo Torero at the AGRODEP Workshop on Analytical Tools for Food Prices
and Price Volatility
June 6-7, 2011 • Dakar, Senegal
For more information on the workshop or to see the latest version of this presentation visit: http://www.agrodep.org/first-annual-workshop
Farmers purchase seeds from multiple brands and dealers to diversify their risk. They typically plant 3-4 brands and 5-8 varieties of corn, with 60% selecting germplasm first before choosing biotech traits. Purchases are made from 2-3 dealers in November and December. 38% of the corn is the latest top-yielding hybrids, with the goal of maximizing yield while minimizing risk through genetic diversity.
The document provides an overview of JBS S.A., a leading global protein producer, for the first quarter of 2010. Key highlights include:
- Net revenue increased 35.4% year-over-year to R$12.55 billion due to acquisitions.
- EBITDA increased 307.5% to R$862 million with margins improving from 2.3% to 6.9%.
- Net profit was R$99.4 million compared to a prior year loss of R$322.7 million.
- The US beef business posted a record EBITDA of US$170.5 million and 6% margins for the quarter.
- Mercosul
Jerzy Plewa, Deputy Director General for International Affairs, DG Agriculture and Rural Development
14th May 2008, Royal Museum for Central Africa in Tervuren, Belgium
The document discusses Monsanto's strategy around seeds and traits for corn. It notes that Monsanto has invested over $5 billion in seeds-and-traits R&D over 10 years. It also discusses Monsanto's leadership in developing and commercializing biotech traits for corn and how the company is focused on delivering total performance to farmers through high-yielding seeds and trait packages. Finally, it provides examples of how drought-tolerant corn in development could create value by accessing new market acres in the U.S., Brazil, and Argentina.
Braskem reported its 3Q10 results, with EBITDA of R$1,030 million. Crackers operated at over 90% capacity. Domestic resin sales rose 17% over 2Q10. Braskem is committed to financial solidity, lowering its net debt/EBITDA ratio. It raised $450 million in perpetual bonds. Integration of Quattor is advancing, with synergies of R$235 million in 2011 EBITDA. Braskem aims to be a global leader in biopolymers and sustainable chemicals through projects like Green PE and expanding use of renewable feedstock.
- The document provides financial results and forecasts for Monsanto Company for the second quarter of 2007 and fiscal year 2007.
- Net sales for the second quarter of 2007 were $2.6 billion, up 15% from the previous year. Earnings per share on an as-reported basis were $0.98, up 25% from the prior year.
- For fiscal year 2007, Monsanto increased guidance and now expects earnings per share of $1.60-1.65, representing 22-26% growth over the previous year, and free cash flow of $875-950 million.
Brett Begemann, Executive Vice President of Monsanto, presented at an investor day on November 8, 2007. He outlined Monsanto's strategic plan to double gross profit from soybeans over the next 5 years through the launch of its Roundup Ready 2 Yield soybean technology. This new technology was shown to provide a 7-11% yield advantage over previous Roundup Ready soybeans. Monsanto planned to launch Roundup Ready 2 Yield on 5-6 million U.S. acres by 2010-2012 and expected it to more than compensate for any competitive offerings in the marketplace.
This document discusses Monsanto's commercial strategy for corn traits and seeds. It outlines three pathways for mid-term growth: 1) increasing penetration and expansion of existing traits like Roundup Ready Corn 2, 2) stacking more traits into seeds, and 3) developing second-generation traits. The strategy aims to supply corn products to three channels of the market through brands like DEKALB and Asgrow, the American Seeds Inc. regional channel, and licensees. Molecular breeding is accelerating the integration of traits into higher performing seeds.
Hugh Grant, Chairman and CEO of Monsanto, presented at the Goldman Sachs Agricultural Biotech Forum. In the presentation, Grant discussed Monsanto's focus on seeds and traits, which have driven strong gross profit growth. He outlined Monsanto's strategy to extend its leadership in seeds and traits through 2010 by leveraging six growth opportunities. Grant also reviewed Monsanto's corn seed and trait performance in the U.S., noting its strength in key maturity zones is translating to increased market share. He projected demand from ethanol will provide a further boost for Monsanto's corn technology. Internationally, Grant noted Monsanto's seed business provides varying levels of profit opportunity in major corn markets.
Seminis is focused on developing new vegetable seed products, particularly in high-value crops like tomatoes, peppers, cucumbers, and melons. One key product is a raised head broccoli variety that enables mechanical harvesting, which can significantly reduce labor costs compared to traditional broccoli harvesting. Seminis is developing commercial raised head broccoli varieties and testing prototypes to prepare for product launches targeting major markets like the U.S., U.K., and Spain. The new variety is expected to bring the cost of harvesting into the value of the seed.
- Monsanto reported strong financial results for the first quarter of 2009, with net sales increasing 29% and net income up 117% compared to the first quarter of 2008.
- Gross profit for Roundup and other glyphosate-based herbicides increased 65% driven by higher prices globally and strength in Brazil.
- Corn and soybean seed and traits segments are performing well with U.S. orders on track and international launches progressing as planned.
- Monsanto reiterated fiscal year 2009 ongoing earnings growth guidance of 20-24% and free cash flow projection of over $1.8 billion.
- Monsanto reported strong financial results for the first quarter of 2009, with net sales increasing 29% and net income up 117% compared to the first quarter of 2008.
- Gross profit for Roundup and other glyphosate-based herbicides increased 65% driven by higher prices globally and strength in Brazil.
- Corn and soybean seed and traits segments are performing well with U.S. orders on track and international launches progressing as planned.
- Monsanto reiterated fiscal year 2009 ongoing earnings growth guidance of 20-24% and free cash flow projection of over $1.8 billion.
This document provides an overview of an investor tour of Seminis Research Headquarters scheduled for August 1-2, 2005. It includes forward-looking statements and discusses various risks and uncertainties that could impact financial results. It also notes that certain non-GAAP financial measures such as free cash flow and return on capital will be used and includes reconciliations to GAAP measures. Finally, it outlines the company and industry overview and research and development overview presentations that will take place during the tour.
1) The document discusses Monsanto's seeds and traits business, which focuses on corn and soybeans.
2) Monsanto has seen strong growth in its seeds and traits segment, with gross profits in this segment growing at a 32% CAGR from 2003-2006.
3) Monsanto believes it can increase its overall gross margin to 51-53% by 2010 by expanding its corn business in the U.S. and internationally, growing other crops like cotton, and developing new traits through its research pipeline.
This document provides an overview of Monsanto's pipeline and commercial opportunities. It summarizes Monsanto's seeds and traits strategy, noting that farmers buy yield which opens opportunities for Monsanto to provide genetic gain through seeds and preserve that gain through technology/traits. The pipeline update highlights progress in corn and cotton breeding programs as well as the addition of Seminis and opportunities it provides. Discovery efforts are fueling pipeline expansion and commercial prospects.
This document provides a financial summary and strategic review for Monsanto for the fourth quarter and full year of 2006. Some key points:
- Net sales for Q4 2006 were $1.39 billion, up 9% from Q4 2005. Full year 2006 net sales were $7.34 billion, up 17% from 2005.
- Reported EPS for Q4 2006 was $-0.27 per share, down 17% from Q4 2005. Full year 2006 reported EPS was $1.25 per share, up 166% from 2005.
- Monsanto has demonstrated leadership in corn and cotton seeds and traits, and sees continued opportunities for market penetration globally.
Terry Crews, Chief Financial Officer of Monsanto, presented at the 35th Annual Investment Conference hosted by Banc of America Securities on September 21, 2005. Monsanto's seeds and traits strategy has driven strong earnings performance, with ongoing EPS growth of 12% in 2003-2004 and an estimated growth rate of 26-29% for 2005. Financial discipline has established seeds and traits as the foundation of Monsanto's strategy, with gross profit from seeds and traits exceeding that of Roundup herbicide in 2003. Monsanto expects to continue accelerating the performance of its seeds and traits business in 2006-2007.
The document discusses Hugh Grant, Chairman and CEO of Lehman Brothers, and provides forward-looking statements for the company. It also discusses using non-GAAP financial measures in presentations and defines terms used such as fiscal year and trademarks. The overview section describes how farmers aim to maximize yield through genetic gain and technology to preserve that gain, representing Monsanto's seed and trait approach.
Hugh Grant, Chairman and CEO of Monsanto Company, presented at a CEO & Investor Conference on February 14, 2006. In his presentation, he discussed:
1) Biotechnology has been rapidly adopted by farmers due to significant economic and environmental benefits it provides, such as increased productivity and yields as well as reductions in pesticide use.
2) Monsanto has a leading commercial portfolio of biotech traits as well as an unmatched research and development pipeline of new traits in development.
3) During the 2005 Midwest drought, Monsanto's YieldGard Rootworm trait demonstrated its value by allowing corn plants to have heartier roots and tap into available moisture, providing over 30 additional bushels per acre
- Monsanto's biotech pipeline is progressing with two projects advancing from Phase 3 to Phase 4 and one project added in sugarcane, accelerating expansion.
- Key yield and stress products are advancing, including drought tolerant corn moving into Phase 4 and higher yielding soybeans into Phase 3.
- Final yield trials show DEKALB corn outyielding competitors with an average 3-year advantage of 11.5 bushels per acre, reinforcing DEKALB's yield leadership.
- New 2009 Deltapine cotton varieties provide greater value to growers, outperforming competitors and existing varieties by 5-12% across regions.
Petrobras is a major international oil company that was originally established as a government monopoly in Brazil. It is now 60% publicly traded with shares listed in Brazil and New York. The company has grown significantly in recent decades and aims to become one of the top five largest publicly traded oil producers by 2020. Petrobras has a competitive advantage in deepwater exploration and production. It also has large proven reserves, particularly from new pre-salt discoveries, that could more than double Brazil's reserves. The company has shown an impressive record of accelerating production growth over the past decades from major new field developments.
1) Monsanto has an opportunity to increase its gross margin in corn through 2010 by gaining market share in the U.S., increasing penetration of stacked traits, and expanding its international corn business.
2) In the U.S., Monsanto can boost profits by capturing more acreage through its branded seed brands, capitalizing on increased ethanol production driving corn demand, and accelerating the adoption of stacked traits.
3) Internationally, Monsanto's hybrid corn seeds provide the highest value in key European and African markets like France, Italy, and South Africa where the company has increased its market share in recent years.
Monsanto's biotech pipeline is progressing with several projects advancing phases or being added. Key projects include drought tolerant corn moving into Phase 4 and higher yielding soybeans in Phase 3. Roundup Ready 2 Yield soybeans were launched and YieldGard VT Pro is in demonstration. Final yield trials show DEKALB corn outperforming competitors. New 2009 Deltapine cotton varieties provide greater value than existing varieties and competition. Roundup Ready 2 Yield soybeans are anticipated by farmers due to expected step change in yields.
Monsanto's biotech pipeline is progressing with several projects advancing phases or being added. Key projects include drought tolerant corn moving into Phase 4 and higher yielding soybeans in Phase 3. Roundup Ready 2 Yield soybeans were launched and YieldGard VT Pro is in demonstration. Final yield trials show DEKALB corn outperforming competitors. New 2009 Deltapine cotton varieties provide greater value than existing varieties and competition. Roundup Ready 2 Yield soybeans are anticipated by farmers due to expected step change in yields.
The document provides an overview of Monsanto's R&D pipeline and progress. Some key points:
1) Monsanto's biotech pipeline is accelerating, with 6 projects advancing phases and 2 new projects added in the past year. Progress is being made on critical drought-tolerant corn and higher-yielding soybeans.
2) The company's investment in breeding continues to yield results, with improvements made to germplasm bases across crops.
3) Guidance for fiscal year 2009 supports a 20%+ growth rate over 2008, with ongoing earnings per share expected to grow 20-24% and free cash flow to exceed $1.8 billion.
Hugh Grant, Chairman and CEO of Monsanto, presented at the Basic Materials Conference on February 21, 2006. He outlined that Monsanto is on track or exceeding expectations for fiscal years 2006 and 2007, with earnings per share growth of up to 20% and free cash flow of $825-900 million projected. Key commercial commitments, including increased US corn and cotton market shares, were also presented.
wyeth Deutsche Bank 32nd Annual Health Care Conferencefinance12
This document summarizes Cavan Redmond's presentation at the Deutsche Bank Health Care Conference on May 3, 2007. It discusses Wyeth's position as the 4th largest biopharmaceutical company globally in terms of biotech sales in 2006. Wyeth's biotech business saw 39% revenue growth in the first quarter of 2007 driven by strong performance of Enbrel and Prevnar. The presentation outlines Wyeth's strategy to further grow its biotech franchise globally with new indications and geographic expansions of Enbrel and Prevnar, as well as innovation in its hemophilia and bone growth portfolios.
This document discusses Monsanto's acquisition of De Ruiter Seeds. Key points include:
1) De Ruiter Seeds is a leading international protected-culture vegetable seed company that will help address gaps in Monsanto's vegetable and fruit seed portfolio in the fast-growing protected-culture segment.
2) Monsanto signed a definitive agreement to acquire De Ruiter Seeds for €546M, expected to be break even in the first full fiscal year and accretive in the second full fiscal year following closing.
3) De Ruiter Seeds is a proven industry leader, delivering strong financial performance with outlook for continued growth, with net sales of $118.6M in 2005, $
1) Monsanto is acquiring De Ruiter Seeds, a leading international protected-culture vegetable seed company, for approximately $800 million.
2) The acquisition strengthens Monsanto's position in the fast-growing protected-culture vegetable seed segment and improves opportunities to capture value through innovation.
3) The addition of De Ruiter Seeds is expected to boost Monsanto's vegetable seed growth outlook, increasing revenue and gross profit projections by more than 20% through 2012 versus original forecasts.
This document provides an overview and highlights of Virgin Media's performance in the fourth quarter of 2006. It discusses the company's achievements over the last 12 months including the Telewest merger and Virgin Mobile acquisition. The fourth quarter saw revenue growth across all segments, strong net additions, and continued ARPU and customer care improvements. Priorities for 2007 include delivering on the new Virgin brand, targeting competitor customers, driving efficiency and improving customer care.
This document provides an overview of Virgin Media's performance in the fourth quarter of 2006. It discusses the company's achievements over the past year including the Telewest merger and Virgin Mobile acquisition. The highlights of Q4 2006 include revenue growth across all segments, strong broadband and TV subscriber additions, and increased triple play penetration. Priorities for 2007 include delivering on the new Virgin brand, targeting competitor customers, driving efficiency and improving customer care.
Virgin Media reported its financial results for the first quarter of 2007. Key highlights include:
1) Strong growth in broadband, TV and mobile contract customers due to compelling offers and marketing campaigns promoting bundled services. However, fixed line customers continued to decline due to increased competition.
2) ARPU was slightly down due to lower fixed line usage, but triple play penetration and Old NTL ARPU increased, pointing to continued ARPU growth.
3) Customer churn improved to 1.6% due to more rigorous credit policies and efficient sales channels, while Sky basics had a minimal impact in Q1.
4) Mobile contract growth remained strong through cable cross-sell, while pre-pay declined season
This document summarizes Virgin Media's performance in the first quarter of 2007. It discusses Virgin Media's progress on key priorities such as brand strength, targeting competitors, cable integration, and cross-sell opportunities. Financial metrics like revenue, customer additions and disconnects, and ARPU are also reviewed. Challenges from increased competition and the impact of Sky's new "Basics" package are addressed.
This document provides a summary of Virgin Media's financial performance in the second quarter of 2007. It discusses declines in revenue due to customer churn related to the loss of Sky basics channels, but notes improving trends in areas like TV and broadband. Key points highlighted include strong growth in video on demand usage, successful bundling of products, expansion of high speed broadband services, and continued strength in the mobile business. The summary also previews upcoming content initiatives and their potential to further drive customer growth and engagement.
This document summarizes Virgin Media's financial performance in the second quarter of 2007. Key points include: losses of Sky basic channels impacted customer churn but TV performance was better than expected; strong mobile contract sales and bundling of products continued; and while ARPU was affected by retention activities, cash flow outlook remains strong. The document provides details on customer additions and disconnects, growth of triple play bundling, and increases in video on demand usage.
This document provides a summary of Virgin Media's financial results for the third quarter of 2007. It notes significant improvements in customer and revenue growth metrics compared to previous quarters. Revenue was up slightly from the second quarter due to growth in the consumer, business services, content, and mobile segments. Operating cash flow also increased due to lower costs and certain one-time benefits. However, proactive investment in customer growth was also noted as impacting operating cash flow. Net debt remained substantial as of the end of the third quarter.
This document provides a summary of Virgin Media's financial results for the third quarter of 2007. It discusses improvements in customer and revenue growth metrics compared to previous quarters. Specifically, it notes record quarterly gross additions and reduced churn. It also summarizes growth in the company's broadband, TV, telephony, mobile, and business services segments. The document concludes with discussions of operating cash flow, revenue, and net debt levels.
The document summarizes an UBS media conference by Acting CEO Neil Berkett of Virgin Media on December 5, 2007. Berkett discussed Virgin Media's transformation through integration, re-engineering growth initiatives. He highlighted opportunities in premium TV, basic pay-TV, free DTV and contract mobile. Berkett also outlined Virgin Media's network advantages in speed and reach, and strategies to increase customer value through volume, ARPU and tenure. Mobile was discussed as an important driver of consumer value through cross-selling. Valuable tax assets were also noted.
The document summarizes an UBS media conference by Acting CEO Neil Berkett of Virgin Media on December 5, 2007. Berkett discussed Virgin Media's transformation through integration, re-engineering growth initiatives, and building the platform for growth. He highlighted opportunities in premium TV, basic pay-TV, free DTV, broadband, and mobile services. Berkett also covered Virgin Media's network advantages, content assets, tax assets, and the significant potential asset value of the company's network, consumer base, mobile business, and content.
This document provides a summary of Virgin Media's financial and operational results for the first quarter of 2008. Key highlights include continued strong growth in broadband and TV customers, record-low cable churn of 1.2%, and stable cable ARPU despite non-recurring benefits in the previous quarter. OCF increased slightly compared to last quarter. Capex remained high at 13.7% of revenue to support network upgrades including faster broadband speeds. Revenue declined slightly due to seasonal factors in certain business units.
This document summarizes Virgin Media's financial and operational results for the first quarter of 2008. Key highlights include continued strong growth in broadband and TV customers, record-low cable churn of 1.2%, and stable cable ARPU despite non-recurring benefits in the previous quarter. OCF was £324 million for Q1 2008, up slightly from the previous quarter. Cash capex was £125 million for network upgrades and expansion.
This document provides a summary of Virgin Media's performance in the second quarter of 2008. It discusses financial results including operating cash flow growth and SG&A reductions. It also reviews operational metrics such as subscriber growth, churn rates, broadband and TV services. Virgin Media saw increased revenue and profitability in Q2 2008 compared to the same period last year.
This document provides a summary of Virgin Media's performance in the second quarter of 2008. It discusses financial results including operating cash flow growth and SG&A reductions. It also reviews operational metrics such as subscriber growth, churn rates, broadband and TV services. Virgin Media saw increased revenue and profitability in Q2 2008 compared to the prior year through lower churn, higher triple-play penetration and a focus on quality customer growth. The company believes its cable network gives it advantages over DSL providers that will increase further after investments are completed.
This document provides a summary of Virgin Media's financial results for the third quarter of 2008. It reports that Virgin Media continued to see growth in key metrics such as on-net customer additions, broadband and TV subscriber growth, and improving triple play penetration. ARPU increased through price increases, cross-selling, and upselling efforts. Mobile contract customer growth was strong through cross-selling to cable customers. Content revenues increased for VMtv but declined for Sit-Up. Overall revenue was flat, while operating cash flow and margins declined slightly compared to last year. Capital expenditures remained high to continue network upgrades and expand service offerings.
This document provides a summary of Virgin Media's financial results for the third quarter of 2008. It reports that Virgin Media continued to see growth in key metrics such as on-net customer additions, broadband and TV subscriber growth, and improving triple play penetration. ARPU increased through price increases, cross-selling, and upselling efforts. Mobile contract customer growth was strong through cross-selling to cable customers. Content revenue increased for VMtv but declined for Sit-Up. Overall revenue was flat, while operating cash flow and margins declined slightly compared to last year. Capital expenditures remained high to continue network investments.
The document discusses Virgin Media's strategy to leverage its network advantages for renewed growth. Key points include plans to: 1) lead in next generation broadband through upgrades to 10Mbps and beyond; 2) lead the on-demand TV revolution through growing video on demand usage and iPlayer views; and 3) leverage mobile as a third screen through bundling mobile services. Virgin Media also aims to build a more efficient customer focused organization through an operational transformation program targeting over £120m in annual cost savings by 2012.
The document discusses Virgin Media's strategy to leverage its network advantages for renewed growth. It aims to lead in next generation broadband, lead the on-demand TV revolution, and leverage mobile as a third screen. Virgin Media has the best broadband economics due to its high market share and lower costs. It is focusing on upgrading customers to higher broadband tiers, growing on-demand TV and video usage, and integrating mobile offerings. The company expects operational transformation to deliver over £120 million in annual cost savings by 2012.
The document provides an agenda and overview for an investor and analyst day being held by Virgin Media in London on November 13, 2008. It includes:
1) A disclaimer stating that forward-looking statements in the document involve risks and uncertainties that could cause actual results to differ materially.
2) An agenda for the day's presentations on Virgin Media's strategy, growth initiatives, network strengths, financial structure and regulatory progress.
3) Introductions of the senior management team who will be presenting.
The document provides an agenda and overview for an investor and analyst day being held by Virgin Media in London on November 13, 2008. It includes:
1) A disclaimer stating that forward-looking statements in the document involve risks and uncertainties that could cause actual results to differ materially.
2) An agenda for the day's presentations on Virgin Media's strategy, growth initiatives, network strengths, financial structure and regulatory progress.
3) Biographies and photos of Virgin Media's management team, including the CEO and heads of key business units.
University of North Carolina at Charlotte degree offer diploma Transcripttscdzuip
办理美国UNCC毕业证书制作北卡大学夏洛特分校假文凭定制Q微168899991做UNCC留信网教留服认证海牙认证改UNCC成绩单GPA做UNCC假学位证假文凭高仿毕业证GRE代考如何申请北卡罗莱纳大学夏洛特分校University of North Carolina at Charlotte degree offer diploma Transcript
The Universal Account Number (UAN) by EPFO centralizes multiple PF accounts, simplifying management for Indian employees. It streamlines PF transfers, withdrawals, and KYC updates, providing transparency and reducing employer dependency. Despite challenges like digital literacy and internet access, UAN is vital for financial empowerment and efficient provident fund management in today's digital age.
Vicinity Jobs’ data includes more than three million 2023 OJPs and thousands of skills. Most skills appear in less than 0.02% of job postings, so most postings rely on a small subset of commonly used terms, like teamwork.
Laura Adkins-Hackett, Economist, LMIC, and Sukriti Trehan, Data Scientist, LMIC, presented their research exploring trends in the skills listed in OJPs to develop a deeper understanding of in-demand skills. This research project uses pointwise mutual information and other methods to extract more information about common skills from the relationships between skills, occupations and regions.
New Visa Rules for Tourists and Students in Thailand | Amit Kakkar Easy VisaAmit Kakkar
Discover essential details about Thailand's recent visa policy changes, tailored for tourists and students. Amit Kakkar Easy Visa provides a comprehensive overview of new requirements, application processes, and tips to ensure a smooth transition for all travelers.
A toxic combination of 15 years of low growth, and four decades of high inequality, has left Britain poorer and falling behind its peers. Productivity growth is weak and public investment is low, while wages today are no higher than they were before the financial crisis. Britain needs a new economic strategy to lift itself out of stagnation.
Scotland is in many ways a microcosm of this challenge. It has become a hub for creative industries, is home to several world-class universities and a thriving community of businesses – strengths that need to be harness and leveraged. But it also has high levels of deprivation, with homelessness reaching a record high and nearly half a million people living in very deep poverty last year. Scotland won’t be truly thriving unless it finds ways to ensure that all its inhabitants benefit from growth and investment. This is the central challenge facing policy makers both in Holyrood and Westminster.
What should a new national economic strategy for Scotland include? What would the pursuit of stronger economic growth mean for local, national and UK-wide policy makers? How will economic change affect the jobs we do, the places we live and the businesses we work for? And what are the prospects for cities like Glasgow, and nations like Scotland, in rising to these challenges?
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...sameer shah
Delve into the world of STREETONOMICS, where a team of 7 enthusiasts embarks on a journey to understand unorganized markets. By engaging with a coffee street vendor and crafting questionnaires, this project uncovers valuable insights into consumer behavior and market dynamics in informal settings."
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...Donc Test
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting, 8th Canadian Edition by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Ebook Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Pdf Solution Manual For Financial Accounting 8th Canadian Edition Pdf Download Stuvia Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Financial Accounting 8th Canadian Edition Ebook Download Stuvia Financial Accounting 8th Canadian Edition Pdf Financial Accounting 8th Canadian Edition Pdf Download Stuvia
South Dakota State University degree offer diploma Transcriptynfqplhm
办理美国SDSU毕业证书制作南达科他州立大学假文凭定制Q微168899991做SDSU留信网教留服认证海牙认证改SDSU成绩单GPA做SDSU假学位证假文凭高仿毕业证GRE代考如何申请南达科他州立大学South Dakota State University degree offer diploma Transcript
Fabular Frames and the Four Ratio ProblemMajid Iqbal
Digital, interactive art showing the struggle of a society in providing for its present population while also saving planetary resources for future generations. Spread across several frames, the art is actually the rendering of real and speculative data. The stereographic projections change shape in response to prompts and provocations. Visitors interact with the model through speculative statements about how to increase savings across communities, regions, ecosystems and environments. Their fabulations combined with random noise, i.e. factors beyond control, have a dramatic effect on the societal transition. Things get better. Things get worse. The aim is to give visitors a new grasp and feel of the ongoing struggles in democracies around the world.
Stunning art in the small multiples format brings out the spatiotemporal nature of societal transitions, against backdrop issues such as energy, housing, waste, farmland and forest. In each frame we see hopeful and frightful interplays between spending and saving. Problems emerge when one of the two parts of the existential anaglyph rapidly shrinks like Arctic ice, as factors cross thresholds. Ecological wealth and intergenerational equity areFour at stake. Not enough spending could mean economic stress, social unrest and political conflict. Not enough saving and there will be climate breakdown and ‘bankruptcy’. So where does speculative design start and the gambling and betting end? Behind each fabular frame is a four ratio problem. Each ratio reflects the level of sacrifice and self-restraint a society is willing to accept, against promises of prosperity and freedom. Some values seem to stabilise a frame while others cause collapse. Get the ratios right and we can have it all. Get them wrong and things get more desperate.
^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Duba...mayaclinic18
Whatsapp (+971581248768) Buy Abortion Pills In Dubai/ Qatar/Kuwait/Doha/Abu Dhabi/Alain/RAK City/Satwa/Al Ain/Abortion Pills For Sale In Qatar, Doha. Abu az Zuluf. Abu Thaylah. Ad Dawhah al Jadidah. Al Arish, Al Bida ash Sharqiyah, Al Ghanim, Al Ghuwariyah, Qatari, Abu Dhabi, Dubai.. WHATSAPP +971)581248768 Abortion Pills / Cytotec Tablets Available in Dubai, Sharjah, Abudhabi, Ajman, Alain, Fujeira, Ras Al Khaima, Umm Al Quwain., UAE, buy cytotec in Dubai– Where I can buy abortion pills in Dubai,+971582071918where I can buy abortion pills in Abudhabi +971)581248768 , where I can buy abortion pills in Sharjah,+97158207191 8where I can buy abortion pills in Ajman, +971)581248768 where I can buy abortion pills in Umm al Quwain +971)581248768 , where I can buy abortion pills in Fujairah +971)581248768 , where I can buy abortion pills in Ras al Khaimah +971)581248768 , where I can buy abortion pills in Alain+971)581248768 , where I can buy abortion pills in UAE +971)581248768 we are providing cytotec 200mg abortion pill in dubai, uae.Medication abortion offers an alternative to Surgical Abortion for women in the early weeks of pregnancy. Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman Fujairah Ras Al Khaimah%^^%$Zone1:+971)581248768’][* Legit & Safe #Abortion #Pills #For #Sale In #Dubai Abu Dhabi Sharjah Deira Ajman
1. BRETT BEGEMANN
Executive Vice President,
International
CREDIT SUISSE FIRST BOSTON
Agrochemicals Conference
London
Feb. 15, 2005
1
2. Forward-Looking Statements
Certain statements contained in this presentation, such as statements concerning the company's anticipated
financial results, current and future product performance, regulatory approvals, currency impact, business and
financial plans and other non-historical facts are quot;forward-looking statements.quot; These statements are based on
current expectations and currently available information. However, since these statements are based on factors that
involve risks and uncertainties, the company’s actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that could cause or contribute to such
differences include, among others: the company's exposure to various contingencies, including those related to
Solutia Inc., litigation, intellectual property, regulatory compliance (including seed quality), environmental
contamination and antitrust; successful completion and operation of recent and proposed acquisitions;
fluctuations in exchange rates and other developments related to foreign currencies and economies; increased
generic and branded competition for the company's Roundup herbicide; the accuracy of the company’s estimates
and projections, for example, those with respect to product returns and grower use of our products and related
distribution inventory levels; the effect of weather conditions and commodity markets on the agriculture business;
the success of the company’s research and development activities and the speed with which regulatory
authorizations and product launches may be achieved; domestic and foreign social, legal and political
developments, especially those relating to agricultural products developed through biotechnology; the company’s
ability to successfully market new and existing products in new and existing domestic and international markets;
the company’s ability to obtain payment for the products that it sells; the company's ability to achieve and maintain
protection for its intellectual property; the effects of the company's accounting policies and changes in generally
accepted accounting principles; the company's ability to fund its short-term financing needs; and other risks and
factors detailed in the company's filings with the U.S. Securities and Exchange Commission. Undue reliance should
not be placed on these forward-looking statements, which are current only as of the date of this release. The
company disclaims any current intention or obligation to revise or update any forward-looking statements or any of
the factors that may affect actual results, whether as a result of new information, future events or otherwise.
2
3. Non-GAAP Financial Information
This presentation may use the non-GAAP financial measures of “free cash flow,” ongoing earnings per share (EPS),
and Return on Capital (ROC). We define free cash flow as the total of cash flows from operating activities and cash
flows from investing activities. A non-GAAP EPS financial measure, which we refer to as EPS on an ongoing basis,
may exclude the impact of restructuring charges, charges associated with the settlement of litigation, gains and
losses on the sale of assets, and certain other items. The specific items that are excluded from, and result in, our
non-GAAP EPS financial measure are clearly identified as such in this presentation. ROC means net income
exclusive of after-tax interest expenses, divided by the average of the beginning year and ending year net capital
employed, as defined in the reconciliation at the end of this presentation. The presentation of free cash flow,
ongoing EPS and ROC is intended to supplement investors’ understanding of our operating performance. These
non-GAAP financial measures may not be comparable to similar measures used by other companies. Furthermore,
these non-GAAP financial measures are not intended to replace net income (loss), cash flows, financial position, or
comprehensive income (loss), as determined in accordance with accounting principles generally accepted in the
United States. The non-GAAP financial measures used in this presentation are reconciled to the most directly
comparable financial measures calculated and presented in accordance with GAAP, which can be found at the end
of this presentation.
Fiscal Year
In this presentation, unless otherwise specified, references to Monsanto’s fiscal years refer to the 12-month period
ending August 31.
Trademarks
Roundup, Roundup Ready, Bollgard, Bollgard II, YieldGard and Vistive are trademarks owned by Monsanto
Company and its wholly-owned subsidiaries.
3
4. Value Shift from Crop Chemicals to Seeds and Traits
Well Under Way
GLOBAL AGRICULTURAL INDUSTRY REVIEW
1996 2003 2008F
$9.1 BILLION
$7.6 BILLION $8.4 BILLION
$0.1
$1.3
$2.7
$2.6
$3.0 $4.5
$3.5 $3.6
$3.8
CROP CHEMICALS GERMPLASM BIOTECH TRAITS
Sources: U.S. 1996-2003 Doane Agrotrak & Seed Studies; 2008 Monsanto estimates
Calendar years
4
5. MARKET LEADERSHIP
Seeds and Traits Are a Growing Contributor to
Monsanto’s Gross Profit
GROSS PROFIT
2001 2003 2005F PRO FORMA
$2.9 BILLION
$2.3 BILLION
$2.6 BILLION
5%
23%
30%
27%
47%
50%
56%
16%
23%
23%
ROUNDUP AND OTHER GLYPHOSATE-BASED SEEDS AND TRAITS
HERBICIDES
SEMINIS
ALL OTHER AG PRODUCTIVITY
5
6. MARKET LEADERSHIP
Monsanto Raises the Bar for Leadership in Global Seeds
with Addition of Seminis
2003 SEED AND TRAIT REVENUE
$3,000
$2,500
$2,000
$ MILLIONS
$1,500
$1,000
$500
$0
MONSANTO MONSANTO LIMAGRAIN SEMINIS BAYER SAKATA
PRO FORMA
DUPONT SYNGENTA KWS TAKII DELTA & DOW
PINE LAND
Sources: Phillips McDougall, Monsanto reports
Calendar year for all companies but Monsanto
Syngenta pro forma for acquisition of Advanta and Golden Harvest (Sources: Phillips McDougall and news releases)
6
7. MARKET LEADERSHIP - BREEDING
Improvements in Corn Seed Breeding Expanding EU/SA
Market Share U.S.
KEY MARKET ACRES EU S. AFRICA
BRAND LICENSED ASI
Corn 80M 30M 7M
AVAILABLE MARKET
Breeding
CREATING VALUE
14% 33% 2% 10% 43%
PERCENT PENETRATED
Monsanto’s branded corn germplasm out-yielded competitors’
• In 2005,
across EU mid-maturities and South Africa in 2004 trials
Monsanto’s
branded seed
Comparable performance in Mediterranean region versus
gained 2 market
share points in leading competitor
EU, 3 points in
Stronger pipeline under development for important EU silage
South Africa
market
• Elite, high-
CORN MARKET SHARE GROWTH
yielding
germplasm
refreshes
45%
12%
product portfolio 40%
10%
at high end of
pricing 8% 35%
• New licensing 6%
strategy for corn 30%
4%
in Europe/Africa
under 25%
2%
development
0% 20%
2001 2002 2003 2004 2001 2002 2003 2004
FRANCE SOUTH AFRICA
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
7
8. MARKET LEADERSHIP - BREEDING
Vistive Moved from Discovery to Launch in Three Years
Through Molecular Breeding KEY MARKET ACRES U.S. BRAZIL ARGENTINA
Vistive 5M TBD TBD
AVAILABLE MARKET
Low Linolenic Soy
CREATING VALUE
0% 0% 0%
PERCENT PENETRATED
First of a three-product step-change in oil profiles
• Contract grown,
value shared. Most oil already under contract with food companies
Monsanto sells
Oil to be in on-the-shelf consumer products in late 2005
to growers,
processors pay
grower premium
OIL PROFILES ALONG THE 3-STEP CHANGE IMPROVEMENT
and royalty to
Monsanto after LINOLENIC LINOLEIC OLEIC SATS
harvest and 18:3 18:2 18:1 18:0 / 16:0
STANDARD
crushing SOYBEAN
• To be stacked
with Mid-Oleic
LOW LIN
before full
market
penetration is MID OLEIC +
LOW LIN
achieved
• 1 acre = ZERO SAT +
approximately MID OLEIC +
500 lbs. of oil LOW LIN
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
8
9. MARKET LEADERSHIP - BREEDING
Seminis Has Largest, Most Diverse Germplasm Pool in
Vegetable Industry LATIN EUROPE- ASIA
KEY MARKET POSITION NAFTA AMERICA AFRICA PACIFIC
Vegetable 1 1 1 1
MARKET POSITION
Breeding
CREATING VALUE
Germplasm investment nearly double that of closest competitor
• Seminis branded
seed recognized Vegetable seed germplasm is proprietary, scarce
globally: Royal
75% of R&D devoted to breeding
Sluis, Petoseed,
Bruinsma, and
Between 20%-25% of commercial products come from new
Asgrow
hybrids introduced in prior two years
Vegetable
• Breeding valued
VEGETABLE FRESHNESS INDEX
for quality,
taste, health
25%
benefits, disease
control 20%
• New seeds have
15%
greatest pricing
opportunity 10%
5%
0%
2002 2003 2004 2005F
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
9
10. MARKET LEADERSHIP - BIOTECHNOLOGY
Biotechnology Is Most Rapidly Adopted Technology in
History of Agriculture
GLOBAL MONSANTO PLANTED BIOTECH ACRES
180
CANOLA
160
COTTON
140
SOYBEANS
ACRES IN MILLIONS
120
CORN
100
80
60
40
20
0
1996 1997 1998 1999 2000 2001 2002 2003 2004
Source: Monsanto estimates
10
11. MARKET LEADERSHIP - BIOTECHNOLOGY
Market Potential for Roundup Ready Corn is Poised to
Accelerate
KEY MARKET AREAS U.S. ARGENTINA
Roundup Ready TARGET MARKET 50M 5M
Corn
CREATING VALUE
PERCENT PENETRATED 32% <1%
Current forecast of 20M acres of Roundup Ready corn in
• U.S. trait fee of 2005 U.S. season
$8-$10 per acre
With European import approval for single trait, market potential
in Monsanto
branded seed now 50M acres in U.S.
• Grower profits
Production plans under way to accelerate growth in 2006
average of $12
per acre on yield U.S. ROUNDUP READY CORN ACREAGE GROWTH
gains alone; 25
additional cost
savings on labor,
20
fuel and MILLIONS OF ACRES
equipment
Provides grower 15
greater
flexibility in 10
weed control
5
0
1998 1999 2000 2001 2002 2003 2004 2005F
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
11
13. MARKET LEADERSHIP - BIOTECHNOLOGY
Introduction of Ingard II Accelerates Monsanto’s
Growth in Australian Cotton Market
KEY MARKET AREAS U.S. AUSTRALIA
TARGET MARKET 10-15M 0.5-0.8M
Cotton Traits
CREATING VALUE
PERCENT PENETRATED 75% 80%
Biotech trait acreage has grown to approximately 600k acres
• Ingard II requires from 275k in 2004
an average of
More than two-thirds of cotton acres planted are Ingard II
85% less
insecticide than varieties
conventional
Approximately 50% of all biotech cotton acres are stacked
cotton
Ingard II and Roundup Ready
• Value reflects
better insect AUSTRALIA MONSANTO BIOTECH ACRES
protection,
higher yields, 100%
% TOTAL ACRES
farmer
80%
convenience and
flexibility 60%
40%
20%
0%
2003 2004 2005
Stacked Ingard/Ingard II RR Cotton
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
13
14. INNOVATION - PIPELINE
Seeds and Traits R&D Is More Than Just Biotechnology;
Two Platforms Drive Pipeline Opportunities
PIPELINE EXAMPLES
ELITE CORN GERMPLASM
FARMER
PHASE IV
BENEFITS
SMALL-ACRE CROPS
Pre-Launch
BREEDING
PROCESSOR PREFERRED CORN
PROCESSOR
PHASE IV
BENEFITS
Pre-Launch
CONSUMER VISTIVE LOW-LIN SOYBEANS
LARGE-ACRE CROPS
BENEFITS PHASE IV
Pre-Launch
ROUNDUP READY FLEX COTTON
FARMER
BIOTECHNOLOGY
PHASE IV
BENEFITS
Pre-Launch
HIGH-LYSINE CORN
PROCESSOR PHASE IV
BENEFITS Pre-Launch
CONSUMER OMEGA-3 SOYBEANS
PHASE II
BENEFITS
Early Development
GENOMICS CONVENTIONAL MOLECULAR CROP ANALYTICS BIOTECHNOLOGY
BREEDING BREEDING
14
15. INNOVATION - BREEDING
Breeding Breakthrough Improves the Taste and
Mouth-Feel of Soy-Based Foods
KEY MARKET ACRES U.S. BRAZIL ARGENTINA
Improved-Protein <1M TBD TBD
AVAILABLE MARKET
Soybeans for Food
CREATING VALUE
0% 0% 0%
PERCENT PENETRATED
Created through breeding
• Contract grown,
technologies
value shared.
Monsanto sells Improves taste and mouth-
to growers,
feel
processors pay
grower premium Consumer applications in
and royalty to
beverages and meat
Monsanto after
alternatives
harvest and
crushing Developed with molecular
markers and analytical
• Small acres, but
high value per screenings to accelerate
acre breeding
Produced in high-yielding
varieties for testing
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
15
16. INNOVATION - BREEDING
Molecular Breeding Can Be Applied to Seminis’ Sweet
Corn Breeding Programs
KEY MARKET POSITION WORLDWIDE
Knowledge Transfer MARKET POSITION 4
to Sweet Corn
CREATING VALUE
Immediate access to broad
• Breeding
corn germplasm base
knowledge
transfer Corn genotyping
increases
capabilities applicable
potential new
across all corn germplasm
product
including sweet corn
offerings
Enables efficient selection
• Molecular
breeding speeds for disease and quality
creation of new
traits using marker-
hybrids
assisted selection
• Accelerated
genetic gains
have potential to
translate to
market share
gains, higher
market value
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Early Development Adv. Development Pre-Launch
16
17. INNOVATION - BIOTECHNOLOGY
Added Flexibility Means Better Weed Control, Greater
Value in Cotton
KEY MARKET ACRES U.S. AUSTRALIA
Roundup Ready AVAILABLE MARKET 10-15M 0.5-0.8M
Flex Cotton
CREATING VALUE
0% 0%
PERCENT PENETRATED
Expanded window of over-the-top application for more
• Value reflects “flexible” weed control
greater
convenience and Increased grower convenience
enhanced weed
Reduced need for specialized spray equipment
control. Lifts the
value of the
8 cotton seed companies currently breeding trait into
Roundup Ready
varieties
trait
• Roundup Ready
Flex Cotton will
be available only
with Bollgard II,
which also
should boost
Bollgard II
adoption
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
17
18. INNOVATION - BIOTECHNOLOGY
High Lysine Enhances Animal Feed, Shifts
Value to Seed
KEY MARKET ACRES U.S. BRAZIL ARGENTINA
High Lysine Corn
4M 1M 4M
AVAILABLE MARKET
CREATING VALUE
0% 0% 0%
PERCENT PENETRATED
• Market value for Lower cost of animal
feed-grade feed ration – lysine –
lysine in roughly
which cannot be
$1 billion
produced by animals,
annually
so must be obtained
• Value shared
through feed
with Cargill
through 50/50 LYSINE TOTALS IN TESTING
Improved amino acid
Renessen joint
balance
venture
WITH GENE
CONTROL
Increased total energy
1,800
FREE LYSINE (PPM)
1,600
TARGET
Excellent performance 1,400
demonstrated in
1,200
1,000
feeding trials to date 800
First of a two-product 600
step-change in lysine
400
200
content 0
U.S.
SOUTH AMERICA
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
18
19. INNOVATION - BIOTECHNOLOGY
Drought Stress Tolerance Will Be a Family of High
Value Traits
KEY MARKET ACRES U.S. BRAZIL ARGENTINA
Drought-Tolerant TBD TBD TBD
AVAILABLE MARKET
Corn
CREATING VALUE
0% 0% 0%
PERCENT PENETRATED
Yield protection on all acres against water deficits
• Pricing depends
Yield enhancement on all acres through improved water use
on choice of
and cost savings on irrigated acres
market
• Stacking with Two gene leads obtained positive results with more than one
weed and insect
transformed event
control
enhances the YIELD INCREASE IN TWO GENE TRIALS
margin
opportunity 3 EVENTS: GENE 1 3 EVENTS: GENE 2
18
30 16
• Irrigation
currently costs 14
25
$50 to $100 per
YIELD INCREASE
12
20
acre 10
15 8
6
(BU/AC)
10
4
5
2
0 0
EVENT 3
EVENT 1 EVENT 2 EVENT 3
EVENT 1 EVENT 2
GERMPLASM 1 GERMPLASM 2
DISCOVERY PHASE I PHASE III
PHASE II PHASE IV LAUNCH
Proof of Concept Adv. Development
Early Development Pre-Launch
19
20. FINANCIAL GROWTH
Gross Profit Growth Accelerates with Addition of Seminis to
Monsanto Businesses
GROSS PROFIT
MONSANTO PRO FORMA1 MONSANTO SEED/TRAIT
PRO FORMA1
7% CAGR AGR
5% C
1
$3,500
$3,500
$3,000
$3,000
$2,500
$ MILLIONS
$ MILLIONS
$2,500
$2,000
$2,000
$1,500
$1,500
$1,000
$1,000
$500
$500
$0
$0
2004 2005F 2006F
2004 2005F 2006F
ROUNDUP AND OTHER
ALL OTHER
SEEDS AND TRAITS
GLYPHOSATE-BASED
HERBICIDES
Pro forma for acquisition of Seminis
1
20
21. FINANCIAL GROWTH
Guidance for Ongoing EPS Reflects Addition of
Seminis Earnings
EPS ON AN ONGOING BASIS
$2.50 • 2005 guidance range
increased to
$2.25 $1.85 to $2.00
• 10% base business
$2.00 growth for 2006
expected on
$1.75 increased 2005
guidance
$1.50 • Earnings in 2005 and
2006 affected by
$1.25 Seminis inventory
step-up
$1.00 • Seminis is expected
to be $0.20 accretive
2004A 2005F 2006F to Monsanto in 2007
PRO FORMA FOR
BASE MONSANTO UPSIDE MONSANTO
ACQUISITION OF
GUIDANCE GUIDANCE
SEMINIS
21
22. FINANCIAL GROWTH
Acquisition Also Contributes to Free Cash Generation
Near-Term
Seminis expected
FREE CASH FLOW
to generate $50M
free cash in 2005
and $75M in 2006
GUIDANCE
PRE-
$950
Current $500M
ACQUISIITON
share repurchase
$700
program will
continue;
$450
scheduled
$200 completion July
2006
-$50 2006F
2005F
2004
Dividends will
continue to be
-$300
considered to
GUIDANCE
-$550 return additional
POST-
value to
ACQUISITION
-$800
shareowners
PRO FORMA FOR ACQUISITION OF SEMINIS
22
23. A Clear Focus To Deliver On Commitments
Market Leadership
Largest global seed and trait company
Global reach in high-value agriculture segments
Technological Innovation
Leading breeding and biotechnology platforms
Proven, highly productive new product pipeline
Financial Growth
EPS and free cash flow growth reflect seeds and traits
leadership
Commitment to return value to shareowners through
dividends, share repurchases, investments
23
24. Reconciliation of Non-GAAP Financial Measures
Reconciliation of Free Cash Flow
Fiscal Year 2006 Fiscal Year 2005 12 Months Ended
$ Millions
Target Target Aug. 31, 2004
Net Cash Provided (Required) by Operations $975 $1,050 $1,261
Net Cash Provided (Required) by Investing Activities $(300) $(1,800) $(262)
Free Cash Flow $675 $(750) $999
Net Cash Provided (Required) by Financing Activities N/A N/A $(243)
Net Increase (Decrease) in Cash and Cash Equivalents N/A N/A $756
Reconciliation of Non-GAAP EPS
$ per share 12 Months Ended 12 Months Ended 12 Months Ended
Aug. 31, 2004 Aug. 31, 2005 Aug. 31, 2006
Net Income (Loss) $0.99 $0.86-$1.06 $2.04 - $2.22
--
$0.36 --
Restructuring Charges -- Net
2004 Discontinued Operations and Related $0.02 -- --
Restructurings-- Net
Goodwill Impairment Charge for Global Wheat $0.24 -- --
Business
-- --
Estimated Purchase Accounting Adjustments $0.65 -- $0.70
-
--
Tax Benefit on Loss from Sale of European Wheat and -- $(0.39)
Barley Business
-- --
$0.68
Solutia-Related Charge
Net Income (Loss) from Ongoing Business $1.61 $1.85 - $2.00 $2.04 - $2.22
24